LaCascia Michael J.'s most recent trade in Foghorn Therapeutics Inc was a trade of 126,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 22, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Foghorn Therapeutics Inc | Michael J. LaCascia | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 126,000 | 126,000 | - | - | Stock Option (right to buy) | |
Foghorn Therapeutics Inc | LaCascia Michael J. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
Foghorn Therapeutics Inc | Michael J. LaCascia | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
Foghorn Therapeutics Inc | Michael J. LaCascia | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 135,000 | 135,000 | - | - | Stock Option (right to buy) |